Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome
- PMID: 30299432
- DOI: 10.1097/MED.0000000000000445
Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome
Abstract
Purpose of review: Polycystic ovarian syndrome (PCOS) is the most common cause of chronic anovulation and hyperandrogenism in young women and represents a true public health concern and an economic burden.
Recent findings: The pathophysiology of PCOS is still not fully understood, but progresses have been made and the relationships between anti mullerian hormone (AMH), follicle stimulating hormone, luteinizing hormone, E2 and androgens have been explored. The follicle excess plays a central role in the syndrome and AMH is definitively a major component of this phenomena.
Summary: The aim of this chapter is to present the recent work studying the role of AMH in the pathophysiology of PCOS and to discuss the improvement that serum AMH assay brings in the diagnosis of PCOS.
Similar articles
-
The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:82-7. doi: 10.1016/j.ejogrb.2016.01.029. Epub 2016 Feb 10. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 26914398 Review.
-
The role of AMH in anovulation associated with PCOS: a hypothesis.Hum Reprod. 2014 Jun;29(6):1117-21. doi: 10.1093/humrep/deu076. Epub 2014 Apr 25. Hum Reprod. 2014. PMID: 24770999
-
Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):552-557. doi: 10.1111/ajo.12647. Epub 2017 Jun 9. Aust N Z J Obstet Gynaecol. 2017. PMID: 28597496
-
Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.Acta Obstet Gynecol Scand. 2013 Dec;92(12):1369-74. doi: 10.1111/aogs.12247. Epub 2013 Oct 15. Acta Obstet Gynecol Scand. 2013. PMID: 23980726
-
Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review.Reprod Biol Endocrinol. 2015 Dec 21;13:137. doi: 10.1186/s12958-015-0134-9. Reprod Biol Endocrinol. 2015. PMID: 26691645 Free PMC article. Review.
Cited by
-
Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.Int J Mol Sci. 2021 Nov 19;22(22):12507. doi: 10.3390/ijms222212507. Int J Mol Sci. 2021. PMID: 34830389 Free PMC article. Review.
-
Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.Front Endocrinol (Lausanne). 2020 Sep 9;11:641. doi: 10.3389/fendo.2020.00641. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33013710 Free PMC article. Review.
-
Insulin-like peptide 5 (INSL5) positively correlates with anti-Müllerian hormone (AMH) in women with the polycystic ovary syndrome: a case-control study.J Ovarian Res. 2022 Oct 28;15(1):118. doi: 10.1186/s13048-022-01052-7. J Ovarian Res. 2022. PMID: 36303231 Free PMC article.
-
The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups.Diabetes Metab Syndr Obes. 2021 Mar 25;14:1419-1424. doi: 10.2147/DMSO.S299558. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 33790608 Free PMC article.
-
Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.Front Endocrinol (Lausanne). 2022 Jun 9;13:881740. doi: 10.3389/fendo.2022.881740. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35757414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials